Toggle navigation
Home
Search
Services
Blog
Contact
About
Best Pharmaceuticals
National Heart, Lung, and Blood Institute
Search grants from National Heart, Lung, and Blood Institute
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC
Delivering contextualizing population data to patients to motivate health care transition preparation
Structural Biology of Amyloid Beta-Protein
Adhesion mechanisms mediating sickle cell vasoocclusion in vivo
Nucleosomal DNA Effect on Mitomycin C Binding
Recently added grants:
A novel molecular cross-talk driving pancreatic cancer progression
Determinants of transdermal drug delivery to the normal and the radiated breast
Administrative Core
Phase 1/2 Study of Modern Immunotherapy in BCG-Relapsing Urothelial Carcinoma of the Bladder - (ADAPT-BLADDER)
Repurposing Clinical ACT Antimalarials for Experimental Melanoma Intervention
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
NIH Intra-Agency Agreements (Y02)
Project #
Y2HO4001-7-0-1
Application #
8175934
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2010
Total Cost
$1,995,430
Indirect Cost
Institution
Name
National Heart, Lung, and Blood Institute
Department
Type
DUNS #
City
State
Country
Zip Code
Comments
Be the first to comment on this grant